"Cystectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Used for excision of the urinary bladder.
| Descriptor ID |
D015653
|
| MeSH Number(s) |
E04.950.774.150
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cystectomy".
Below are MeSH descriptors whose meaning is more specific than "Cystectomy".
This graph shows the total number of publications written about "Cystectomy" by people in this website by year, and whether "Cystectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 7 | 9 |
| 2003 | 2 | 4 | 6 |
| 2004 | 4 | 0 | 4 |
| 2005 | 0 | 1 | 1 |
| 2006 | 11 | 3 | 14 |
| 2007 | 2 | 3 | 5 |
| 2008 | 7 | 4 | 11 |
| 2009 | 4 | 3 | 7 |
| 2010 | 10 | 4 | 14 |
| 2011 | 1 | 2 | 3 |
| 2012 | 4 | 1 | 5 |
| 2013 | 2 | 0 | 2 |
| 2014 | 5 | 0 | 5 |
| 2015 | 3 | 3 | 6 |
| 2016 | 3 | 7 | 10 |
| 2017 | 2 | 3 | 5 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 5 | 5 | 10 |
| 2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cystectomy" by people in Profiles.
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. Int J Urol. 2025 Sep; 32(9):1195-1202.
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study. Int J Urol. 2025 Aug; 32(8):1007-1013.
-
Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network. Urol Oncol. 2025 07; 43(7):441.e11-441.e18.
-
The Financial Burden of Localized and Metastatic Bladder Cancer. Eur Urol. 2025 May; 87(5):536-550.
-
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation. Eur J Surg Oncol. 2025 Mar; 51(3):109543.
-
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Gu?rin in Patients with Bacillus Calmette-Gu?rin-Unresponsive Non-Muscle Invasive Bladder Cancer. Eur Urol Oncol. 2025 Apr; 8(2):469-476.
-
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Gu?rin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group. Eur Urol Oncol. 2025 Feb; 8(1):216-229.
-
Oncologic outcomes of pelvic organ-preserving radical cystectomy vs. Standard radical cystectomy: A systematic review and meta-analysis. Urol Oncol. 2025 05; 43(5):275-285.
-
Predicting Response to Intravesical Bacillus Calmette-Gu?rin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort. J Urol. 2025 Feb; 213(2):192-204.
-
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer. N Engl J Med. 2024 Oct 03; 391(13):1206-1216.